The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
Abstract
Normal polymorphic size variation of the exon 1 CAG microsatellite of the androgen receptor (AR) is associated with prostate cancer, benign prostatic hyperplasia and male infertility. Furthermore, abnormal expansion of the satellite leads to Kennedy's disease. We have shown recently that the AR N-terminal domain (NTD), which contains the polyglutamine (polyQ) stretch (encoded by the CAG repeat), functionally interacts with the C-termini of p160 coactivators. In the present study we explored possible AR CAG size effects on the p160 coactivator-mediated transactivation activity of the receptor. First, we mapped the p160 coactivator interaction on the AR NTD and found an interaction surface between amino acids 351 and 537. Although this region is 'downstream' from the polyQ stretch, it is still within the AR NTD, is implicated in constitutive transactivation activity of the receptor, and thus might be subject to polyQ size modulation. Indeed, cotrans- fection experiments in cultured prostate epithelial cells, using AR constructs of varying CAG sizes and p160 coactivator expression vectors, revealed that increased polyQ length, up to a size of 42 repeats, inhibited both basal and coactivator-mediated AR transactivation activity. AR expression in these cells, on the other hand, was unaffected by the same increased CAG repeat size range. We conclude that the AR NTD contributes to AR transactivation activity via functional interactions with p160 coactivators and that increasing polyQ length negatively affects p160-mediated coactivation of the AR. This molecular mechanism thus might explain, at least in part, the observed phenotypic effects of the AR CAG size polymorphism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Improved method for high efficiency transformation of intact yeast cells
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. H. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,261
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. R. L., Wilson, E. M., Lubahn, D. B., Harding, A. E., & Fischbeck, K. H. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,784
Schiestl, R. H., & Gietz, R. D. (1989) · Current Genetics · doi:10.1007/bf00340712 · Cited by 2,131
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., & Rosenfeld, M. G. (1997) · Nature · doi:10.1038/42652 · Cited by 1,283
Regulation of Transcription by a Protein Methyltransferase
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S.-M., Schurter, B. T., Aswad, D. W., & Stallcup, M. R. (1999) · Science · doi:10.1126/science.284.5423.2174 · Cited by 1,211
Chamberlain, N. L., Driver, E. D., & Miesfeld, R. L. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.3181 · Cited by 1,156
Functional domains of the human glucocorticoid receptor
Giguère, V., Hollenberg, S. M., Rosenfeld, M. G., & Evans, R. M. (1986) · Cell · doi:10.1016/0092-8674(86)90339-9 · Cited by 918
Coactivator and corepressor complexes in nuclear receptor function
Xu, L., Glass, C. K., & Rosenfeld, M. G. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80021-5 · Cited by 902
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C. H., & Kantoff, P. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3320 · Cited by 873
The nuclear receptor ligand-binding domain: structure and function
Moras, D., & Gronemeyer, H. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80015-x · Cited by 843
Danielian, P. S., White, R., Lees, J. A., & Parker, M. G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05141.x · Cited by 803
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2920 · Cited by 660 · cited 2×
“Recently, however, it was revealed that p160 coactivators interact with the NTDs of the estrogen receptor (ER) (35, 36 ), the progesterone receptor (PR) (37) and the AR (38) in addition to binding to their respective LBDs.”
BackgroundTranscriptional Activation Modulated by Homopolymeric Glutamine and Proline Stretches
Gerber, H.-P., Seipel, K., Georgiev, O., Höfferer, M., Hug, M., Rusconi, S., & Schaffner, W. (1994) · Science · doi:10.1126/science.8303297 · Cited by 617
Co-activators and co-repressors in the integration of transcriptional responses
Torchia, J., Glass, C., & Rosenfeld, M. G. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80014-8 · Cited by 595
Ingles, S. A., Ross, R. K., Yu, M. C., Haile, R. W., Irvine, R. A., La Pera, G., & Coetzee, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.166 · Cited by 583
Self-citationDMSO-enhanced whole cell yeast transformation
Hill, J., Donald, K. A. I. G., & Griffiths, D. E. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5791 · Cited by 530
Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., & Brinkmann, A. O. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1396 · Cited by 523 · cited 1×
“The NTD contains a ligand-independent, constitutive activation function (generally referred to as AF-1) that is repressed by the apo- or unliganded LBD in the wild-type (wt) AR ( 23 ).”
BackgroundIrvine, R. A., Yu, M. C., Ross, R. K., & Coetzee, G. A. (1995) · PubMed · Cited by 522
Self-citationTut, T. G., Ghadessy, F. J., Trifiro, M. A., Pinsky, L., & Yong, E. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4385 · Cited by 512
Lubahn, D. B., Brown, T. R., Simental, J. A., Higgs, H. N., Migeon, C. J., Wilson, E. M., & French, F. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9534 · Cited by 452
Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford, J. L., Just, J. J., Gibbs, M., Wicklund, K. G., Neal, C. L., Blumenstein, B. A., & Ostrander, E. A. (1997) · PubMed · Cited by 447
Stenoien, D. L., Cummings, C. J., Adams, H. P., Mancini, M. G., Patel, K., DeMartino, G. N., Marcelli, M., Weigel, N. L., & Mancini, M. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.731 · Cited by 444
Kazemi-Esfarjani, P., Trifiro, M. A., & Pinsky, L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.4.523 · Cited by 443
Ding, X. F., Anderson, C. M., Ma, H., Hong, H., Uht, R. M., Kushner, P. J., & Stallcup, M. R. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.2.0065 · Cited by 434
Self-citationJenster, G., van der Korput, H. A. G. M., Trapman, J., & Brinkmann, A. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7341 · Cited by 419
Onate, S. A., Boonyaratanakornkit, V., Spencer, T. E., Tsai, S. Y., Tsai, M.-J., Edwards, D. P., & O'Malley, B. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12101 · Cited by 417
Estrogen Receptor Activation Function 1 Works by Binding p160 Coactivator Proteins
Webb, P. (1998) · Molecular Endocrinology · doi:10.1210/me.12.10.1605 · Cited by 384
La Spada, A. R., Roling, D. B., Harding, A. E., Warner, C. L., Spiegel, R., Hausmanowa-Petrusewicz, I., Yee, W.-C., & Fischbeck, K. H. (1992) · Nature Genetics · doi:10.1038/ng1292-301 · Cited by 368
Ikonen, T., Palvimo, J. J., & Jänne, O. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29821 · Cited by 363
Mhatre, A. N., Trifiro, M. A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., Rouleau, G., & Pinsky, L. (1993) · Nature Genetics · doi:10.1038/ng1093-184 · Cited by 357
Reduced androgen receptor gene expression with first exon CAG repeat expansion
Choong, C. S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1527 · Cited by 310
Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer
Langley, E., Zhou, Z.-X., & Wilson, E. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29983 · Cited by 280
Mitotic regulator protein RCC1 is complexed with a nuclear ras-related polypeptide.
Bischoff, F. R., & Ponstingl, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10830 · Cited by 277
Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility
Ross, R. K., Coetzee, G. A., Pearce, C. L., Reichardt, J. K. V., Bretsky, P., Kolonel, L. N., Henderson, B. E., Lander, E., Altshuler, D., & Daley, G. (1999) · European Urology · doi:10.1159/000019909 · Cited by 264
Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene
Dowsing, A. T., Yong, E., Clark, M., McLachlan, R. I., de Kretser, D. M., & Trounson, A. O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08413-x · Cited by 258
Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.
McInerney, E. M., Tsai, M. J., O'Malley, B. W., & Katzenellenbogen, B. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10069 · Cited by 256
Multiple Signal Input and Output Domains of the 160-Kilodalton Nuclear Receptor Coactivator Proteins
Ma, H., Hong, H., Huang, S.-M., Irvine, R. A., Webb, P., Kushner, P. J., Coetzee, G. A., & Stallcup, M. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6164 · Cited by 256
Self-citationCREB-binding protein in androgen receptor-mediated signaling
Aarnisalo, P., Palvimo, J. J., & Jänne, O. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2122 · Cited by 255
CREB Binding Protein Is a Coactivator for the Androgen Receptor and Mediates Cross-talk with AP-1
Frønsdal, K., Engedal, N., Slagsvold, T., & Saatcioglu, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31853 · Cited by 222
Hsiao, P.-W., Lin, D.-L., Nakao, R., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20229 · Cited by 221
Berrevoets, C. A. (1998) · Molecular Endocrinology · doi:10.1210/me.12.8.1172 · Cited by 212
Doesburg, P., Kuil, C. W., Berrevoets, C. A., Steketee, K., Faber, P. W., Mulder, E., Brinkmann, A. O., & Trapman, J. (1997) · Biochemistry · doi:10.1021/bi961775g · Cited by 209
Molecular Mechanisms of Androgen Action
Lindzey, J. K., Kumar, M. V., Grossman, M., Young, C. Y. F., & Tindall, D. J. (1994) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61151-6 · Cited by 176
McEwan, I. J., & Gustafsson, J.-Å. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8485 · Cited by 176
Arbizu, T., Santamaría, J., Gomez, J., Quílez, A., & Serra, J. P. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90022-9 · Cited by 174
Transcriptional activation and transient expression of the human androgen receptor
Gao, T., Marcelli, M., & McPhaul, M. J. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00097-0 · Cited by 169
Trinucleotide repeats in the human androgen receptor: a molecular basis for disease
Choong, C. S., & Em, W. (1998) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0210235 · Cited by 155
The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
Giovannucci, E. L., Platz, E. A., Stampfer, M. J., Chan, A. T., Krithivas, K., Kawachi, I. I., Willett, W. C., & Kantoff, P. W. (1999) · Urology · doi:10.1016/s0090-4295(98)00468-3 · Cited by 128
Chamberlain, N. L., Whitacre, D. C., & Miesfeld, R. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26772 · Cited by 127
Chromosomal analysis of human prostatic adenocarcinoma cell lines.
Ohnuki, Y., Marnell, M., Babcock, M. S., Lechner, J. F., & Kaighn, M. E. (1980) · PubMed · Cited by 87
Butler, R. K., Leigh, P. N., McPhaul, M. J., & Gallo, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.121 · Cited by 85
Giovannucci, E. L., Stampfer, M. J., Chan, A. T., Krithivas, K., Gann, P. H., Hennekens, C. H., & Kantoff, P. W. (1999) · The Prostate · Cited by 71
Differential transactivation by the androgen receptor in prostate cancer cells
Snoek, R., Bruchovsky, N., Kasper, S., Matusik, R. J., Gleave, M. E., Sato, N., Mawji, N. R., & Rennie, P. S. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980901)36:4<256::aid-pros7>3.0.co;2-d · Cited by 59
N-terminal sequences of the human androgen receptor in DNA binding and transrepressing functions
Gast, A., Schneikert, J., & Cato, A. C. B. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00176-3 · Cited by 33
Cited by
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 942
Nelson, W. G., De Marzo, A. M., & Isaacs, W. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021562 · Cited by 918
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Metadata
- Authors
- Irvine, R. A.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01-22
- Volume
- 9
- Issue
- 2
- Pages
- 267-274
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2130538948
- Cited by
- 267
- References
- 57
- FWCI
- 19.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.